MedPath

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

Phase 2
Completed
Conditions
Reduction of Hypertrophic Skin Scarring
Interventions
Registration Number
NCT01730339
Lead Sponsor
Pfizer
Brief Summary

The study will compare how well PF-06473871 works versus placebo in reducing skin scarring after scar revision surgery of existing breast scars. The study will also evaluate the safety of PF-06473871 in healthy adult subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria
  • Subjects must have hypertrophic (raised) breast scars from previous surgery
  • Subjects must be healthy
Exclusion Criteria
  • Currently pregnant or pregnant during the 6 months, prior to inclusion in the study or breast-feeding.
  • Presence of history of breast cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 1PF-06473871-
Group 2PF-06473871-
Primary Outcome Measures
NameTimeMethod
Physician Global Assessment Using Physician Overall Opinion Question of Patient and Observer Scar Assessment Scale (POSAS)Week 24

Physician global assessment was performed using the overall opinion question of the POSAS scale. Physicians were asked to rate the severity of the participant's scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (worst imaginable scar). Within participant treatment difference was assessed between the treatment regimens each participant received.

Secondary Outcome Measures
NameTimeMethod
Patient Global Assessment Using Overall Opinion of Patient and Observer Scar Assessment Scale (POSAS)Week 8, 11, 18, 24

Patient global assessment was performed using the overall opinion question of the POSAS scale. Participants were asked to rate the severity of their scar compared to normal skin. The overall opinion scale score ranged from 1 (normal skin) to 10 (very different from normal skin). Within participant treatment difference was assessed between the treatment regimens each participant received

Physician Scar Assessment Using Complete Patient and Observer Scar Assessment Scale (POSAS)Week 8, 11, 18, 24

Physician scar assessment was performed using 10-point POSAS scale. Physician rated each of the items (vascularity, pigmentation, thickness, relief, pliability, surface area and overall opinion) for a scar on a score of 1 (normal skin) to 10 (worst scar imaginable). Within participant treatment difference was assessed between the treatment regimens each participant received. Data for overall opinion scale score at Week 24 was not presented in this outcome measure because the data was reported separately under primary outcome measure 1.

Patient-Reported Scar Evaluation Questionnaire (PR-SEQ) Symptoms and Appearance Domains ScoreWeek 8, 24

PR-SEQ questionnaire consisted of 30 different attributes of scars that included following four dimensions: appearance (5 attributes), symptoms (3 attributes), bothersomeness (8 attributes), and impacts on the quality of life (physical and emotional wellbeing \[14 attributes\]). Each question had 5 possible responses: not at all (0), slightly (1), moderately (2), very (3), and extremely (4). Participants completed an abbreviated version which included only the Symptoms and Appearance dimensions to evaluate treatment outcomes. Each of the item scores were transformed into a 0 to 100 scale. Each dimension score was calculated from averaging the transformed scores (0-100 scaled) for specified items. Each domain score ranged from 0 to 100, with higher scores indicating higher severity. Within participant treatment difference was assessed between the treatment regimens each participant received.

Physician and Participant Photoguide Scar Assessment Scale ScoreWeek 8, 11, 18, 24

Physician and participants rated severity of each scar using a photonumeric guide on a scale ranging from 1 to 5 (where 1 = minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe). Within participant treatment difference was assessed between the treatment regimens each participant received.

Trial Locations

Locations (39)

University of California Irvine - Dermatology Research

🇺🇸

Irvine, California, United States

Perimeter Outpatient Surgery Center

🇺🇸

Atlanta, Georgia, United States

Sanctuary Mediacal Center

🇺🇸

Boca Raton, Florida, United States

Mercy Clinic Heart and Vascular

🇺🇸

St. Louis, Missouri, United States

Long Island Plastic Surgical Group, P.C.

🇺🇸

Manhasset, New York, United States

Luxe Plastic Surgery

🇺🇸

Sugar Land, Texas, United States

Bayside Ambulatory Center

🇺🇸

Miami, Florida, United States

The Hunstad Kortesis Center for Cosmetic Surgery

🇺🇸

Huntersville, North Carolina, United States

Plastic Surgery and Laser Institute of San Diego

🇺🇸

La Jolla, California, United States

Scripps Memorial-Ximed Medical Center

🇺🇸

La Jolla, California, United States

Laser Skin Surgery Center of NY

🇺🇸

New York, New York, United States

Office of Paul M. Glat ,MD

🇺🇸

Bala Cynwyd, Pennsylvania, United States

Anthony DeMeo, MD

🇺🇸

Walnut Creek, California, United States

Atlanta APC Plastic Surgery

🇺🇸

Conyers, Georgia, United States

Altus Research

🇺🇸

Lake Worth, Florida, United States

Charles Hanson MD

🇺🇸

Walnut Creek, California, United States

Kavali Plastic Surgery and Skin Renewal Center

🇺🇸

Atlanta, Georgia, United States

Body Aesthetic Research Center

🇺🇸

Saint Louis, Missouri, United States

Spivey Station Surgery Center

🇺🇸

Jonesboro, Georgia, United States

Long Island Plastic Surgical Group, P.C

🇺🇸

Garden City, New York, United States

Virginia Clinical Research, Inc.

🇺🇸

Norfolk, Virginia, United States

Health Concepts

🇺🇸

Rapid City, South Dakota, United States

Clinica La Luz

🇪🇸

Madrid, Spain

Magyar Honvedseg-Egeszsegugyi Kozpont

🇭🇺

Budapest, Hungary

Hospital Santa Creu I Sant Pau

🇪🇸

Barcelona, Spain

Advanced Cosmetic Surgery Clinic of Walnut Creek

🇺🇸

Walnut Creek, California, United States

PIH Health Plastic Surgery and Aesthetic Medicine

🇺🇸

Whittier, California, United States

Connall Consmetic Surgery

🇺🇸

Tualatin, Oregon, United States

PIH health

🇺🇸

Whittier, California, United States

Stephan Baker, MD PA

🇺🇸

Coral Gables, Florida, United States

Timothy P. Connall, MD PC

🇺🇸

Tualatin, Oregon, United States

Advanced Medical Resarch ,Inc

🇺🇸

Atlanta, Georgia, United States

Meridian Center for Surgical Excellence, LLC

🇺🇸

Tualatin, Oregon, United States

Noahklinik,Klinik Plastische, Rekonstruktive und Asthetische Chirurgie, Handchirurgie am Roten Kreuz

🇩🇪

Kassel, Hessen, Germany

Fort Bend Imaging

🇺🇸

Sugar Land, Texas, United States

Black Hill Surgical Hospital

🇺🇸

Rapid City, South Dakota, United States

University of South Florida

🇺🇸

Tampa, Florida, United States

Northwestern University Diagnostic Testing Center

🇺🇸

Chicago, Illinois, United States

Northwestern University,Division of Plastic Surgery

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath